David Bruning Named Chief Executive Officer of StageBio

MT. JACKSON, Va., Feb. 12, 2024 /PRNewswire/ — StageBio, a leading provider of GLP-compliant histology, pathology, image analysis and archiving services for both preclinical and clinical research, is pleased to announce the appointment of David Bruning as Chief Executive Officer. Having…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks